Gilead Community Home Health I Arlington, TX - 76017

Gilead Community Home Health I is categorized under Churches, Temples, and Shrines in Arlington, TX and active since 2006.

Gilead Community Home Health I was established in 2006, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Churches, Temples, and Shrines business, which does work in the B2C market, and is classified as a Churches, Temples, and Shrines, under code number 813110 by the NAICS.

If you are seeking more information, feel free to contact Samuel Abiodun Eseyin at the company’s single location by writing to 730 Greenridge Drive, Arlington, Texas TX 76017 or by phoning (352) 622-4148. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Gilead Community Home Health I
Contact Person: Samuel Abiodun Eseyin
Address: 730 Greenridge Drive, Arlington, Texas 76017
Phone Number: (352) 622-4148
Annual Revenue (USD): $0 to $49.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Churches, Temples, and Shrines
SIC Code: 8661
NAICS Code: 813110
Share This Business:

Gilead Community Home Health I was started in 2006 to provide professional Churches, Temples, and Shrines under the SIC code 8661 and NAICS code 813110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.

Feel free to contact Samuel Abiodun Eseyin for inquiries that concern Gilead Community Home Health I by calling the company number (352) 622-4148, as your correspondence is most welcome. Additionally, the physical location of the single location of Gilead Community Home Health I can be found at the coordinates as well as the street address 730 Greenridge Drive in Arlington, Texas 76017.

For its online presence, you may visit Gilead Community Home Health I’s website at and engage with its social media outlets through on Twitter and on Facebook.